GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

300534

CNE100002CP5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
7.17 ^CNY	+2.28%		-2.71%	-27.36%

30/05	Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024	CI
17/05	Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager	MT

An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.

June 05, 2023

An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SZSE:300534) for CNY 234.5 million on June 5, 2023.

Latest news about Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024	31/05	CI
Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager	17/05	MT
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Proposes Final Cash Dividend for 2023	24/04	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023	23/04	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD cancelled the transaction announced on July 17, 2023	21/03	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	17/23/17	CI
Longshenrongfa Pharmaceutical Renews Food Production License	14/23/14	MT
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD announced that it expects to receive CNY 485.796067 million in funding from Gansu Pharmaceutical Investment Group Co., Ltd., Gansu Great Wall Xinglong Silk Road Fund Management Co., Ltd. and other investors.	17/23/17	CI
An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.	05/23/05	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
Chinese Shares Rebound; Longshenrongfa Pharma Rises 3.9% on Renewal of Drug Production License	15/23/15	MT
Gansu Longshenrongfa Pharma Renews Drug Production License	15/23/15	MT
Drug Regulator Approves Changes to Longshenrongfa Pharma's Drug Production License	16/23/16	MT
Longshenrongfa Pharma Gets Nod for Proposed Changes in License	10/23/10	MT
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd completed the acquisition of 70% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd.	07/23/07	CI
Longshenrongfa Pharma Gets Provincial Regulator's Nod for Cough Capsules	06/23/06	MT
Gansu Longshenrongfa Leases Properties to Affiliates	14/22/14	MT
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Gansu Longshenrongfa Pharmaceutical Industry CO. ,LTD Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Gansu Longshenrongfa Pharmaceutical Industry CO. ,LTD Reports Earnings Results for the Full Year Ended December 31, 2021	11/22/11	CI
Chinese Shares End Lower; Pharmaceutical Stlocks Suffer Huge Losses After WuXi Biologics' US Sanction	11/22/11	MT

Chart Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Duration

Period

Chart Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

More charts

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is a company mainly engaged in research and development, production and sales of Chinese traditional medicine. The Company operates two segments. The Pharmaceutical Manufacturing segments is involved in the production and sale of Chinese traditional medicine, health food and raw materials. Its primary product is Yuanhuzhitong dripping pills, which is used for the treatment of stomach pain, rib pain and headache. The Company also produces other drugs, including compound salvia miltiorrhiza tablets, anti-inflammatory and gallbladder tablets, as well as Sanqi injury tablets. The Sales and Logistics segment operates logistics and distribution business.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD	-27.36%	293M
ELI LILLY AND COMPANY	+55.08%	815B
NOVO NORDISK A/S	+44.25%	654B
JOHNSON & JOHNSON	-6.48%	354B
MERCK & CO., INC.	+22.03%	337B
ABBVIE INC.	+10.68%	302B
ASTRAZENECA PLC	+18.45%	247B
ROCHE HOLDING AG	+2.09%	229B
NOVARTIS AG	+13.03%	219B
AMGEN INC.	+9.42%	171B

Other Pharmaceuticals

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Equities

300534

CNE100002CP5

Pharmaceuticals

An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.

Latest news about Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Chart Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals